LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 51.50
-2.20 (-4.10%)
Aug 19, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 4.33 billion as of August 19, 2026. Its market cap has increased by 113.10% in one year.
Market Cap
4.33B
Enterprise Value
3.62B
Revenue
414.67M
Ranking
n/a
PE Ratio
11.23
Stock Price
51.50
ChartMarket Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 4.33B, an increase of 151.33%. That is a compound annual growth rate of 4.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 4.33B | 65.49% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alar Pharmaceuticals | 6.61B |
| SCI Pharmtech | 6.38B |
| Formosa Laboratories | 6.28B |
| Orient Pharma | 5.36B |
| Panion & Bf Biotech | 5.01B |
| Orient EuroPharma | 4.20B |
| Tien Liang BioTech | 4.12B |
| Easywell Biomedicals | 3.74B |